For example, Novo Nordisk is exploring semaglutide in large-scale clinical trials for Alzheimers, while other biotech startups are assessing GLP-1 analogs in treating opioid dependency
BMJ, 335(7631), 1194-1199
But in some cases, doctors may prescribe either of these drugs off-label for this purpose
ACHIEVE-5, the most clinically challenging of the trials, enrolled adults with a mean diabetes duration of 15 years who were already on titrated insulin glargine a population in which additional A1C reduction is notoriously difficult
These challenges stem from: Reduced gastrointestinal motility Increased fluid and sodium losses Frequent gastrointestinal symptoms like nausea, bloating, constipation, and diarrhea (Do et al., 2021, p
Flow cytometry T Cells were centrifuged to remove culture medium and re-suspended with staining buffer